Hims & Hers stock jumps 13% after narrower loss in Q2

Hims & Hers Health Inc. (HIMS) shares rallied nearly 13% in the aftermarket Monday after the telehealth company reported a narrower-than-expected loss for its second quarter and revenue that was above expectations. Hims & Hers lost $7.2 million, or 3 cents a share, in the quarter, compared with $19.7 million, or 10 cents a share, in the second quarter of 2022. Revenue rose 83% to $208 million, Hims & Hers said. Analysts polled by FactSet expected the company to report a loss of 5 cents a share on sales of $205 million. The company guided for revenue of $217 million to $222 million in the third quarter, and full-year revenue between $830 million and $850 million, which are also above consensus on FactSet.

-Claudia Assis

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-07-23 1656ET

Copyright (c) 2023 Dow Jones & Company, Inc.